Insulin Aspart Protamine and Insulin Aspart

Product NDC
73070-200
11-digit product format
730700200
Labeler code
73070
Product ID
73070-200_ec67820c-4008-4894-b933-34b28704221d
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
insulin aspart
Dosage form
INJECTION, SUSPENSION
Route
SUBCUTANEOUS
Labeler
Novo Nordisk Pharma, Inc.
Application
BLA021172
Marketing category
BLA
Marketing start
2001-11-01
Substance
INSULIN ASPART
Active strength
100 [iU]/mL
Pharmacologic classes
Insulin Analog [EPC], Insulin [CS]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Insulin Aspart Protamine and Insulin Aspart
Brand name suffix
Mix 70/30
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
INSULIN ASPART100 [iU]/mL

Harmonized Identifiers#

Field, Values table
FieldValues
UniiD933668QVX
Rxcui351297, 847191

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
24eab60a-55c8-40c1-8c86-7ed01a7a8befProduct name120240227
09fb02dd-baf0-4f67-b464-599bf26324b6Product name220200323
6a6ef80c-37d6-4e02-aa78-fce7b811234eProduct name220200323
91ae268d-ee0f-6988-629d-5065a4376a50Product name220200323

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
73070-200-11Insulin Aspart Protamine and Insulin AspartMix 70/301 in 1 CARTONINJECTION, SUSPENSION17
73070-200-11Insulin Aspart Protamine and Insulin AspartMix 70/3010 mL in 1 VIAL, GLASSINJECTION, SUSPENSION107

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
73070-200-11ML - Milliliter73070-200460789cc-4742-43b3-8666-71943b583c3612020-01-03

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
73070-200INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30 (INSULIN ASPART) INJECTION, SUSPENSION [NOVO NORDISK PHARMA, INC.]7Current NDC, Legacy NDC, 2 package rows20230315_fc94baa4-3606-48bc-a781-9617ab6960ef.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
847191insulin aspart protamine / insulin aspart 70/30 in 3 ML Pen InjectorPSNfc94baa4-3606-48bc-a781-9617ab6960ef7
351297insulin aspart protamine / insulin aspart 70/30 Injectable SuspensionPSNfc94baa4-3606-48bc-a781-9617ab6960ef7
8471913 ML insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Pen InjectorSCDfc94baa4-3606-48bc-a781-9617ab6960ef7
351297insulin aspart protamine, human 70 UNT/ML / insulin aspart, human 30 UNT/ML Injectable SuspensionSCDfc94baa4-3606-48bc-a781-9617ab6960ef7
351297insulin analog, aspart mixed 70/30 100 UNT/ML Injectable SuspensionSYfc94baa4-3606-48bc-a781-9617ab6960ef7
847191insulin, aspart protamine, human 70 UNT/ML / insulin, aspart, human 30 UNT/ML per 3 ML Pen InjectorSYfc94baa4-3606-48bc-a781-9617ab6960ef7

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
73070-200-11730700200111 VIAL, GLASS in 1 CARTON (73070-200-11) / 10 mL in 1 VIAL, GLASS2019-09-100000-00-00NoNoCurrent